Pediatrix Medical
330 hedge funds and large institutions have $5B invested in Pediatrix Medical in 2017 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 97 increasing their positions, 127 reducing their positions, and 60 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
25% more capital invested
Capital invested by funds: $4B → $5B (+$998M)
0.73% more ownership
Funds ownership: 99.21% → 99.94% (+0.73%)
8% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 60
2% less funds holding
Funds holding: 337 → 330 (-7)
24% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 127
47% less call options, than puts
Call options by funds: $8.02M | Put options by funds: $15.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
+$117M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$98.9M |
| 3 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
+$75.1M |
| 4 |
HM
HealthCor Management
New York
|
+$59.5M |
| 5 |
Pzena Investment Management
New York
|
+$45.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$107M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$63M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$59.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$39.9M |
| 5 |
BlackRock
New York
|
-$30.3M |
MD Hedge Fund Activity: Q4 2017 in Review
330 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2017, worth a combined $5B — up 25% from $4B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of MD and 55 opened new positions — a net loss of 5 holders — while 127 trimmed existing stakes and 97 added.
The largest buyer was Elliott Management, opening a new position worth an estimated $117M. The largest seller was Longview Partners, exiting entirely with an estimated $107M sold.
- 330 institutional investors held Pediatrix Medical (MD) as of Q4 2017, down from 337 in Q3 2017.
- Funds reported $5B of Pediatrix Medical stock for Q4 2017, up 25% quarter-over-quarter.
- 55 funds opened new Pediatrix Medical positions in Q4 2017 and 60 closed out, a net change of -5 holders.
- The largest Pediatrix Medical buyer in Q4 2017 was Elliott Management, an estimated $117M added.
- The largest Pediatrix Medical seller in Q4 2017 was Longview Partners, an estimated $107M sold.
Based on aggregated 13F filings for Q4 2017.